secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001493152-24-017024
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition extends business combination deadline to May 18, 2024 with $66,667 deposit
--------------------------------------------------------------------------------

- Citius Pharma deposited $66,667 into trust to extend deadline from April 18 to May 18, 2024.
- Extension funded by unsecured promissory note issued to Citius Pharma; note bears no interest, repayable at close.
- Sponsor may extend up to seven additional months through Nov 18, 2024 with similar monthly deposits.
- Merger agreement with Citius Oncology dated October 23, 2023 remains pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224017024/0001493152-24-017024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224017024/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer